AI-Based Digital Biomarker Could Assist in Early Intervention in High-Risk COVID-19 Patients – HospiMedica

Posted on by

Image: AI-Based Digital Biomarker Could Assist in Early Intervention in High-Risk COVID-19 Patients (Photo courtesy of Business Wire)

The National Cancer Institute (NCI) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health (NIH Bethesda, MA, USA) have awarded a contract to PhysIQ (Chicago, IL, USA) to develop an AI-based COVID-19 Decompensation Index (CDI) Digital Biomarker to address the rapid decline of high-risk COVID-19 patients. The new early warning system under development could allow providers to intervene sooner when a COVID-19 patient is clinically surveilled from home and begins to worsen. Rather than relying on point measurements, such as temperature and SpO2, that are known to be lagging or insensitive indicators of COVID-19 decompensation, continuous multi-parameter vital signs will be used to establish a targeted biomarker for COVID-19.

PhysIQ will develop and validate a CDI algorithm that builds off existing wearable biosensor-derived analytics generated by physIQs pinpointIQ end-to-end cloud platform for continuous monitoring of physiology. The data will be gathered through a clinical study of COVID-19 positive patients and build upon work already in-place for monitoring COVID-19 patients convalescing at home. For patients who participate in the program, physiological data will be collected before and after their admission to the hospital.

In the development phase of this project, physIQ and its clinical partner will monitor participants who are confirmed COVID-19 positive, whether recovering at home or following a discharge from the hospital. During the validation phase, physIQ will evaluate lead time to event statistics, decompensation severity assessments, and the ability for CDI to predict decompensation severity. The study is designed to capture data from a large, diverse population to investigate CDI performance differences among subgroups based on sex/gender and racial/ethnic characteristics. The project will not only enable the development and validation of the CDI, but also collect rich clinical data correlative with outcomes and symptomology related to COVID-19 infection. The index will build on physIQs prior FDA-cleared, AI-based multivariate change index (MCI) that has amassed more than 1.5 million hours of physiologic data, supporting development of this targeted digital biomarker for COVID-19.

Despite the technological advances and attention paid to COVID-19, the healthcare community is still monitoring patient vitals the very same way as we did in the 1800s, said Steven Steinhubl MD, Director of Digital Medicine at Scripps Translational Science Institute (STSI) and a physIQ advisor. With the advances in digital technology, AI and wearable biosensors, we can deliver personalized medicine remotely giving caregivers new tools to proactively address this pandemic. For that reason alone, this decision by the NIH has the potential to have a monumental impact on our healthcare system and how we manage COVID-19 patients.

Related Links:The National Institutes of Health (NIH)PhysIQ

See the original post here:
AI-Based Digital Biomarker Could Assist in Early Intervention in High-Risk COVID-19 Patients - HospiMedica

Bioengineering threats rated as a top biosecurity risk – E&T Magazine

Posted on by

A global team of experts has put together a list of the most urgent biosecurity threats, with bioengineering threats such as DNA-based surveillance among the top-ranked concerns.

The exercise was facilitated by the Centre for Existential Risk (CSER) and the BioRISC project, both based at the University of Cambridge. A group of 41 academics and figures from industry and government submitted 450 questions facing the UK government regarding biological security. These were then debated, voted on and ranked to define the 80 most urgent questions.

The questions were sorted into six categories: bioengineering; communication and behaviour; disease threats; governance and policy; invasive alien species, and securing biological materials and securing against misuse.

The line-up published in PLOS ONE includes questions around whether data from social media platforms should be used to help detect early signs of emerging pathogens; custom DNA synthesis; threats from human-engineered agents, andhow to incorporate biosecurity into science education.

In the year before the pandemic, the UK was ranked second in the world for global health security by the Global Health Security Index a confidence underpinned by its 2018 Biological Security Strategy, said CSERs Dr Luke Kemp, who led the research. Clearly, improvements are needed and not just to be ready for a future Covid-19-like crisis.

We need to plan for a biosecure future that could see anything from brain-altering bioweapons and mass surveillance through DNA databases to low-carbon clothes produced by microorganisms. Many of these seem to lie in the realm of science fiction, but they do not. Such capabilities in bioengineering could prove even more impactful, for better or worse, than the current pandemic.

An international team anonymously scored the 80 issues to produce a priority list of 20 challenges. These weredivided into the most immediate (likely to be faced within the next five years); those on a five-to-10-year timeline, and those a decade or further in the future.

Kemp describes these 20 threats as ranging from the promising to the petrifying.

One of the most immediate threats is surveillance via DNA databases. The Chinese government has already used blood sampling to target the Uighur population, Kemp said, and commercial DNA databases could become the next frontier of surveillance capitalism.

The possibility of using genetic databases for mass surveillance will only grow in coming years, particularly with the rise of new tracking and monitoring methods, powers and apps during the Covid-19 response.

A high-ranked issue for the longer term was malicious uses of neurochemistry. According to the team of experts, advances in bioengineering and neuroscience could lead to beneficial new drugs but also new weapons.

Imagine a world in which law enforcement uses drugs to placate and control crowds, greatly diminishing the promise of non-violent protest movements on climate and social justice, Kemp said. Regulation is critical at both the international and national level. We need to ensure that new insights into the human brain are not weaponised for either the army or police force.

Kemp added: The world, not just the UK, needs a thoughtful, transparent and evidence-based way of identifying emerging issues in biosecurity and bioengineering. Whether it be a new flu pandemic, new bioweapons, or new ways to sequester carbon, forewarned is forearmed.

Sign up to the E&T News e-mail to get great stories like this delivered to your inbox every day.

More:
Bioengineering threats rated as a top biosecurity risk - E&T Magazine

COVID-19 Vaccine Trial Participant: ‘It’s the Right Thing to Do’ – Healthline

Posted on by

This summer, Jonathan Penman, 24, a college student at the University of Nebraska Omaha, enrolled in a clinical trial of an experimental vaccine for COVID-19.

The virus, he said, was a wake-up call.

I did the vaccine trial because I have a couple of grandmothers who live at our familys home, and my mom works in a preschool, Penman told Healthline. There are people close to me who are susceptible to the virus.

Penman is a participant in the phase 2 trial of mRNA-1273, a vaccine candidate from Moderna, a pharmaceutical company in Cambridge, Massachusetts.

Penman had to drive only a few minutes from his apartment in Omaha to take part in the trial at Meridian Clinical Research.

He received the second of two vaccine injections 2 weeks ago.

I was the first one in the Omaha area to do this trial, he said. So far, so good. Im a little tired from the second injection. Theres a little malaise, but thats about it.

Penman thinks that no matter what happens, he made the right decision.

I think its certainly possible that this could save my life. But we, of course, have no way of knowing, he said.

Penman is grateful that his girlfriend, Morgan, and his friends were supportive of his decision to enter the trial.

I ran this by my girlfriend, who is in nursing school, and she was like, Yeah, if you think you should, do it, go for it, he said.

We have had lot of discussions about this. A few people we know and in my family are anti-vaccine. So, it is a conflict, but not anything major, he added.

Penman said he has friends whove had COVID-19.

I have encouraged people on my Facebook page to do the trial because its the right thing to do. I also encourage them to please wear a mask, he said.

Penman said that thankfully, no one close to him has died from the virus.

I have no idea if I have been exposed or not, he said. But as part of the trial, they have done the swabs. Had I been exposed, that would have showed up there.

The first COVID-19 test he took was before the vaccination, just to make sure he didnt have it.

It came back negative, so I took the first shot, he said. They did my vital signs, it was all good. Then a month later, we did the same thing, and again it was negative.

Penman said the trial wasnt intrusive. But he checked it out before he went through with it.

I Googled it, and the whole concept of the trial works. It makes sense, he said. Its not just a typical vaccination. It attacks the RNA and DNA structure of the virus. That is serious bioengineering. Thats pretty cool.

Moderna is deploying its so-called mRNA platform to develop its vaccine.

While most vaccines use injected viruses to initiate an antibody response, Modernas technology uses viral genetic material RNA to produce the antigens that allow the body to learn to respond to the novel coronavirus.

Moderna is testing to see if its vaccine can help the immune system produce effective antibodies against the virus so that, in case of infection, the virus doesnt cause illness.

As of September 11, more than 23,000 people were enrolled in Modernas phase 3 trial.

All participants will be given an injection half of them with the vaccine, half of them with a placebo. Each group is given a second injection 28 days later.

The total participant enrollment plan for the trial is 30,000.

Why has Moderna been able to make it to a phase 3 trial with relative speed compared with some of the larger U.S. pharmaceutical companies?

Our mRNA platform was already built. It gave us speed, Ray Jordan, Modernas chief corporate affairs officer, told Healthline.

We began making doses for 30,000 participants when we were still in a phase 1 trial, Jordan said. It looked like it was not smart fiscal management. But you take that risk so you can move that much more rapidly.

Jordan explained that the company has been working on vaccines using this technology for a decade. The company has nine vaccine candidates in development against everything from respiratory infections to infections transmitted from mother to baby.

Jordan noted that more than 1,900 participants have been enrolled in Modernas infectious disease vaccine trials in the United States, Europe, and Australia. These are trials other than the one for the novel coronavirus.

People say that we got the virus into the clinic in 63 days. But its really been 10 years and 63 days, Jordan said.

When it comes to the development of a COVID-19 vaccine, no one knows for sure what will happen in the coming months or even years.

But theres increasing though guarded optimism in the scientific community that there will be a vaccine or more than one thats effective.

President Trump has said he wants to develop a vaccine as soon as possible, even if the phase 3 trials arent completed. In early August, Trump said he was optimistic that a vaccine would be ready by Election Day on November 3.

Late last month, Dr. Stephen Hahn, the commissioner of the Food and Drug Administration (FDA), said his agency could consider emergency use authorization or approval for a COVID-19 vaccine before phase 3 trials are complete.

But the chief executive officers at nine of the largest Western pharmaceutical companies with a vaccine being studied wrote a letter pledging that in their efforts to develop a COVID-19 vaccine, they wont take shortcuts and will adhere to the scientific process.

We, the undersigned biopharmaceutical companies, want to make clear our on-going commitment to developing and testing potential vaccines for COVID-19 in accordance with high ethical standards and sound scientific principles, the pledge reads.

The executives who signed the pledge are from Moderna, AstraZeneca, BioNTech, Pfizer, Novavax, Sanofi, GlaxoSmithKline, Johnson & Johnson, and Merck.

Explaining why they wrote the letter, Pfizer CEO Albert Bourla, DVM, PhD, told NBC News, We saw it as critical to come out and reiterate our commitment that we will develop our products, our vaccines, using the highest ethical standards and the most scientific processes.

COVID-19 vaccine clinical trials are also being run by such companies as CanSino Biologics, Inovio, Sinovac, Gamaleya Research Institute of Epidemiology and Microbiology, CureVac, and Clover Biopharmaceuticals.

Russia and China are also developing vaccines.

Penman is optimistic about the possibilities of having a COVID-19 vaccine relatively soon.

Meanwhile, his eyes are firmly focused on the future.

Penman wants to get a federal emergency management position. He plans to join the National Guard and is trying to get a commission through the Reserve Officers Training Corps (ROTC).

Im going to try to get an officer position in the government. I would like to work in Homeland Security. But honestly, whatever is available, he said.

Penman has developed an interest in the concept of government intervention and public health since he decided to enroll in the clinical trial.

Im just curious about it, he said. Will the vaccine be mandatory? And what does that say about civil liberties? To what extent will government make it mandatory?

Penman said he has been reading lately about how the United States is one of the only countries where people are protesting the wearing of masks.

Its interesting. We are pretty defensive in this country about our liberties, he said.

But I encourage people to do the right thing. I encourage people to wear a mask. I have been exposed. Ive had friends around me who have gotten it. But some people just dont take it seriously.

Originally posted here:
COVID-19 Vaccine Trial Participant: 'It's the Right Thing to Do' - Healthline

Intestinal Organoid Built That Looks and Functions Like Real Tissue – Genetic Engineering & Biotechnology News

Posted on by

Organoids, which originate from stem cells, are a tool with great potential for modeling tissue and disease biology. The idea is to build miniature tissues and organs that accurately resemble and behave like their real counterparts. But there have been limitations to their development. A new study has taken organoids a step further by inducing intestinal stem cells to form tube-shaped epithelia with an accessible lumen and a similar spatial arrangement of crypt- and villus-like domains to that in vivo. These mini-intestines also retain key physiological hallmarks of the intestine and have a notable capacity to regenerate.

The work is published in Nature in the paper titled, Homeostatic mini-intestines through scaffold-guided organoid morphogenesis.

Organoids could complement animal testing by providing healthy or diseased human tissues, expediting the lengthy journey from lab to clinical trial. Beyond that, organoid technology may hold promise, in the long-term, to replace damaged tissues or even organs in the future. For example, by taking stem cells from a patient and growing them into a new liver, heart, kidney, or lung.

So far, established methods of making organoids come with considerable drawbacks: stem cells develop uncontrollably into circular and closed tissues that have a short lifespan, as well as non-physiological size and shape, all of which result in overall anatomical and/or physiological inconsistency with real-life organs.

Now, scientists from the group led by Matthias Ltolf, PhD, professor at EPFLs Institute of Bioengineering, have found a way to guide stem cells to form an intestinal organoid that looks and functions just like real tissue. The method exploits the ability of stem cells to grow and organize themselves along a tube-shaped scaffold that mimics the surface of the native tissue, placed inside a microfluidic chip.

The researchers used a laser to sculpt the gut-shaped scaffold within a hydrogel, a soft mix of crosslinked proteins found in the guts extracellular matrix supporting the cells in the native tissue. Aside from being the substrate on which the stem cells could grow, the hydrogel thus also provides the form or geometry that would build the final intestinal tissue.

Once seeded in the gut-like scaffold, within hours, the stem cells spread across the scaffold, forming a continuous layer of cells with its characteristic crypt structures and villus-like domains. Then came a surprising result: the scientists found that the stem cells arranged themselves in order to form a functional tiny gut.

It looks like the geometry of the hydrogel scaffold, with its crypt-shaped cavities, directly influences the behavior of the stem cells so that they are maintained in the cavities and differentiate in the areas outside, just like in the native tissue, said Ltolf. The stem cells didnt just adapt to the shape of the scaffold, they produced all the key differentiated cell types found in the real gut, with some rare and specialized cell types normally not found in organoids.

Intestinal tissues are known for the highest cell turnover rates in the body, resulting in a massive amount of shed dead cells accumulating in the lumen of the classical organoids that grow as closed spheres and require weekly breaking down into small fragments to maintain them in culture. The introduction of a microfluidic system allowed us to efficiently perfuse these mini-guts and establish a long-lived homeostatic organoid system in which cell birth and death are balanced, said Mike Nikolaev, a graduate student and the first author of the paper.

The researchers demonstrated that these miniature intestines share many functional features with their in vivo counterparts. For example, they can regenerate after massive tissue damage and they can be used to model inflammatory processes or host-microbe interactions in a way not previously possible with any other tissue model grown in the laboratory.

In addition, this approach is broadly applicable for the growth of miniature tissues from stem cells derived from other organs such as the lung, liver, or pancreas, and from biopsies of human patients. Our work, explained Ltolf, shows that tissue engineering can be used to control organoid development and build next-gen organoids with high physiological relevance, opening up exciting perspectives for disease modeling, drug discovery, diagnostics, and regenerative medicine.

See more here:
Intestinal Organoid Built That Looks and Functions Like Real Tissue - Genetic Engineering & Biotechnology News

Global Fumaric Acid (Cas 110-17-8) Market report study covers the breakdown data with Production, Consumption, Revenue and forecast to 2026 – PRnews…

Posted on by

Global Fumaric Acid (Cas 110-17-8) Market 2015-2026:Size, Share, Future Market Development Status, Growth Opportunities and Forecast Market Statistics.

Global Fumaric Acid (Cas 110-17-8) reports present valuable industry insights and comprehensive forecast study. The report studies the global and regional presence of Fumaric Acid (Cas 110-17-8) industry. Key highlights of the report include main inclinations towards growth factors, development opportunities and feasibility study of the market.

The well-established players of Fumaric Acid (Cas 110-17-8), their market presence, revenue analysis, and growth strategies are presented in this report. This is an extensive study covering various applications, product types, geographical regions, and estimated Fumaric Acid (Cas 110-17-8) market value. Market drivers, growth opportunities during the forecast period is analyzed in this report. Growth rate and production value are analyzed for Fumaric Acid (Cas 110-17-8) regions and countries from 2015-2019.

List Of Key Players

IsegenThirumalai ChemicalJiangsu Jiecheng BioengineeringSuzhou Youhe Science and TechnologyPolyntFuso ChemicalsSealong BiotechnologyChangzhou Yabang ChemicalYantai Hengyuan BioengineeringNIPPON SHOKUBAIBartek IngredientsChangmao Biochemical EngineeringXST Biological

Fumaric Acid (Cas 110-17-8) Market Segmentation: By Types

Technical GradeFood Grade

Fumaric Acid (Cas 110-17-8) Market Segmentation: By Applications

Food and Beverage IndustryUnsaturated PolyesterOthers

Download Free Sample Pdf Report @ https://www.globalmarketers.biz/report/chemicals-and-materials/global-fumaric-acid-(cas-110-17-8)-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/153566#request_sample

Competitive landscape scenario among well-established players, market dynamics, threats to the development and market risk is studied in this report. The report explains diverse business strategies implemented by top players of Fumaric Acid (Cas 110-17-8) market. Fumaric Acid (Cas 110-17-8) industry growth is explained in terms of revenue (USD Million) across regions like North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

A decisive market statistics are presented based on product type, end users, applications. Forecast market statistics will pave the way to estimate futuristic market development and growth opportunities. The pertinent facts and market numbers are presented which are gathered from regulatory authorities. Dominating factors influencing the growth of dominant market players and their position is analyzed in this report.

Fumaric Acid (Cas 110-17-8) industry news, plans & policies, market drivers, analysis of upstream raw material suppliers and downstream buyers of Fumaric Acid (Cas 110-17-8) is carried out in this report. On regional and country level market share, production value, gross margin analysis, consumption ratio, import-export scenario, and SWOT analysis is covered. Fumaric Acid (Cas 110-17-8) forecast study enlists the market value (in USD) and volume forecast for each region, product type, and applications.

InquiryHere For More Details https://www.globalmarketers.biz/report/chemicals-and-materials/global-fumaric-acid-(cas-110-17-8)-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/153566#inquiry_before_buying

To provide a clear Fumaric Acid (Cas 110-17-8) industry structure the report is divided into 12 chapters as follows:

Chapter 1, States the product definition, specifications, pictures, classification and varied applications of Fumaric Acid (Cas 110-17-8);

Chapter 2, Covers the price structure and industry structure covering the cost of raw materials, manufacturing cost, supplier detail of Fumaric Acid (Cas 110-17-8) industry;

Chapter 3, Lists the technical specifications of Fumaric Acid (Cas 110-17-8) covering the capacity, production volume, manufacturing base, R&D status, and sources;

Chapter 4, Represents the market analysis, sales channel, pricing trend, and import-export scenario of Fumaric Acid (Cas 110-17-8);

Chapter 5 and 6, Studies the regional presence of Fumaric Acid (Cas 110-17-8) market across North America, Europe, Asia-Pacific, Latin America, Middle East & Africa. Also, Fumaric Acid (Cas 110-17-8) Market analysis by Type is covered in this report;

Chapter 7 and 8, Fumaric Acid (Cas 110-17-8) market analysis by application and major manufacturers is covered in this report;

Chapter 9, Global and Regional Fumaric Acid (Cas 110-17-8) trend analysis by different applications and product types is mentioned in this chapter;

Chapter 10, Enlist the regional and international Fumaric Acid (Cas 110-17-8) import-export scenario, utilization ratio, and supply chain analysis;

Chapter 11, The consumer analysis is covered in this chapter;

Chapter 12, Presents the key research findings, conclusion, analyst views, data sources, and in-depth research methodology;

The gist of the report highlights is as follows:

Browse Detailed Table Of [emailprotected] https://www.globalmarketers.biz/report/chemicals-and-materials/global-fumaric-acid-(cas-110-17-8)-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/153566#table_of_contents

See more here:
Global Fumaric Acid (Cas 110-17-8) Market report study covers the breakdown data with Production, Consumption, Revenue and forecast to 2026 - PRnews...

Livestock manure properties and pollution prevention Ohio Ag Net – Ohio’s Country Journal and Ohio Ag Net

Posted on by

By Harold Keener, Fuqing Xu, Mary Wicks

Land application of livestock manure provides nutrients such as nitrogen, phosphorous and potassium (NPK) to field crops and is generally the most accepted and economical use for recycling these nutrients. However, land application of manure has been a contributor to severe outbreaks of harmful algal blooms in the Western Lake Erie Basin and Grand Lake St. Marys. The algal blooms have generated health concerns for those using these lakes as sources of drinking water or for recreation. Runoff of total and dissolved reactive P (DRP) is often the limiting nutrient for freshwater algal blooms. Previous studies have shown that the concentration of water-extractable P (WEP) in manure (expressed as lb WEP/lb dry matter) can help predict DRP in runoff.Thus, for a given level of P application per acre, reducing the WEP/P level in manure would reduce total WEP application, thereby reducing the potential for P runoff from land applied manure and associated algal blooms.

Previous studies at OSU and by others on WEP in manure indicate that WEP can be affected by manure storage conditions, such as temperature, storage time, and agitation frequency. During 2018-2019 OSU researchers conducted lab and on-farm studies to evaluate the effect of storage conditions and time on WEP/P ratios for liquid swine and dairy manure (moisture 85-98.5%). For solid poultry manure (moisture less than 70%) only on farm studies were done.These studies showed the following:

Earlier bench scale studies by other researchers have evaluated the effect of incorporating dairy, swine and poultry manure into the soil before rainfall. Those studies showed that the DRP (i.e., WEP) runoff potential for incorporation of surface applied manure was not significantly different compared to soil with no manure application.

Management implications

Results of the 2018-19 Ohio studies indicate that long term storage of liquid swine and dairy manures can reduce the WEP/P of manure, but it does not eliminate the potential for DRP in runoff from surface applied manures. Results also showed that liquid dairy manure would result in the highest levels of WEP/acre for a given application rate of P/acre for the livestock manures investigated.Previous research by others tells us to incorporate manure, especially liquid swine and dairy, to reduce the risk of nutrient runoff. Note that Ohio regulations provide guidelines for manure application during winter months as well as restrictions for impaired watersheds, such as Grand Lake St. Marys or the Western Lake Erie Basin, and for permitted livestock or poultry facilities. For more information, go toagri.ohio.govand click on Conserving Resources.Dr. Harold Keener is a Professor Emeritus, Fuqing Xu was a Research Scientist, and Mary H. Wicks is a Program Coordinator in the Department of Food, Agricultural and Biological Engineering of The Ohio State University.E-mail:keener.3@osu.edu;wicks.14@osu.edu. Phone: (330)202-3533.This column is provided by the OSU Department of Food, Agricultural and Biological Engineering, OSU Extension, Ohio Agricultural Research & Development Center, and the College of Food, Agricultural and Environmental Sciences.

Excerpt from:
Livestock manure properties and pollution prevention Ohio Ag Net - Ohio's Country Journal and Ohio Ag Net

Two University of Chicago researchers elected to National Academy of Medicine – UChicago News

Posted on by

University of Chicago faculty members Melody Swartz and Holly J. Humphrey have been elected members of the National Academy of Medicineone of the highest honors in the field.

Swartz, the William B. Ogden Professor of Molecular Engineering at the Pritzker School of Molecular Engineering, was honored for pioneering contributions to the fields of lymphatic physiology, cancer research and immunotherapy. She holds a joint appointment in the Ben May Department for Cancer Research and is co-founder of the Chicago Immunoengineering Innovation Center.

Swartzs research focuses on gaining a deeper understanding of how the lymphatic system regulates immunity in homeostasis and disease, particularly in cancer and chronic inflammation. Her lab applies this knowledge to develop novel immunotherapeutic approaches to cancer, including lymph node-targeting vaccines. Her quantitative and interdisciplinary approach draws on bioengineering, immunobiology, physiology, cell biology and biomechanics.

Swartzs many honors include a MacArthur Fellowship (2012), as well as her election to the National Academy of Arts and Sciences (2018).

Humphrey, the Ralph W. Gerard Emeritus Professor in Medicine at the University, is currently president of the Josiah Macy Jr. Foundation. The academy honored Humphrey, MD83, for transforming medical education learning environments by creating cultures of equity, diversity, and belonging that prepare future health professionals to care for diverse populations and address social determinants of health.

Following an internal medicine residency, pulmonary and critical care fellowship, and chief residency at the University of Chicago, she served for 14 years as director of the Internal Medicine Residency Program. During her tenure as dean for medical education, her signature programs focused on equity, diversity and inclusion, mentoring, and professionalism.

She is also the chair of the Kaiser Permanente Bernard J. Tyson School of Medicines Board of Directors, chair emeritus of the American Board of Internal Medicine and of the American Board of Internal Medicine Foundation, and a past president of the Association of Program Directors in Internal Medicine.

Established originally as the Institute of Medicine in 1970 by the National Academy of Sciences, the National Academy of Medicine addresses critical issues in health, science, medicine, and related policy and inspires positive actions across sectors. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

Follow this link:
Two University of Chicago researchers elected to National Academy of Medicine - UChicago News

Global Wearable Physical Capacity Evaluation System Market Competitive Environment, Growth Drivers, Validation and Segmentation By 2026|| Hocoma,…

Posted on by

Global Wearable Physical Capacity Evaluation System Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Global Wearable Physical Capacity Evaluation System Market Report offers an entire study of the Impact of COVID-19 on Wearable Physical Capacity Evaluation System Market, Industry Outlook, Opportunities in Market, and Expansion By 2026 and also taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of this also as a future scenario of the worldwide Wearable Physical Capacity Evaluation System industry. Research techniques like PESTLE and SWOT analysis are deployed by the researchers. They need also provided accurate data on Wearable Physical Capacity Evaluation System production, capacity, price, cost, margin, and revenue to help the players gain a clear understanding of the general existing and future market situation.

>>> Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Wearable Physical Capacity Evaluation System Market:

Wearable Physical Capacity Evaluation System Market competition by top manufacturers/Key player Profiled:Hocoma, LiteGait, BTS Bioengineering, MIE Medical Research, Techno Concept, Tekscan, Inc., BioMed Jena, Am Cube, Novel DE, GaitUp, Exel, ReTiSense, Sensor Medica, H/p/cosmos, MediTouch

The study objectives of Wearable Physical Capacity Evaluation System Market report are: 1.To identify opportunities and challenges for Global Wearable Physical Capacity Evaluation System.2.To provide insights about factors affecting market growth. To analyze the Wearable Physical Capacity Evaluation System market based on various factors- price analysis, supply chain analysis, SWOT analysis, etc.3.To identify and analyze the profile of leading players involved within the manufacturing of worldwide Wearable Physical Capacity Evaluation System.4.To provide country-level analysis of the market regarding the present Wearable Physical Capacity Evaluation System market size and future prospective.5.To examine competitive developments like expansions, new product launches, mergers & acquisitions, etc., in Global Wearable Physical Capacity Evaluation System.6.To provide a detailed analysis of the market structure alongside forecast of the varied segments and sub-segments of the worldwide Wearable Physical Capacity Evaluation System market.

At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were infected with COVID-19 disease, and major countries around the world have implemented foot prohibitions and work stoppage orders. Except for the medical supplies and life support products industries, most industries have been greatly impacted, and Wearable Physical Capacity Evaluation System industries have also been greatly affected.

In the past few years, the Wearable Physical Capacity Evaluation System market experienced a growth of xx, the global market size of Wearable Physical Capacity Evaluation System reached xx million $ in 2020, of what is about xx million $ in 2015.

From 2015 to 2019, the growth rate of global Wearable Physical Capacity Evaluation System market size was in the range of xxx%. At the end of 2019, COVID-19 began to erupt in China, Due to the huge decrease of global economy; we forecast the growth rate of global economy will show a decrease of about 4%, due to this reason, Wearable Physical Capacity Evaluation System market size in 2020 will be xx with a growth rate of xxx%. This is xxx percentage points lower than in previous years.

As of the date of the report, there have been more than 20 million confirmed cases of CVOID-19 worldwide, and the epidemic has not been effectively controlled. Therefore, we predict that the global epidemic will be basically controlled by the end of 2020 and the global Wearable Physical Capacity Evaluation System market size will reach xx million $ in 2025, with a CAGR of xxx% between 2020-2025.

Segmentation by Product:

Posture Analysis SystemGaint Analysis System

Segmentation by Application:

HospitalClinicRehabilitation Centre

Click Here For Best Discount: https://www.reporthive.com/request_customization/2525930

Regions Covered in these Report:

Asia Pacific (China, Japan, India, and Rest of Asia Pacific)Europe (Germany, the UK, France, and Rest of Europe)North America (the US, Mexico, and Canada)Latin America (Brazil and Rest of Latin America)Middle East & Africa (GCC Countries and Rest of Middle East & Africa)

Global Wearable Physical Capacity Evaluation System Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Wearable Physical Capacity Evaluation System Market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons To Buy: Make strategic business decisions using in-depth historic and forecast market data associated with the Wearable Physical Capacity Evaluation System market, and every category within it.Extensive price charts draw particular pricing trends within recent yearsPosition yourself to realize the most advantage of the Wearable Physical Capacity Evaluation System markets growth potentialTo understand the latest trends of the Wearable Physical Capacity Evaluation System marketTo understand the impactful developments of key players within the market, their strategic initiatives and comprehensively study their core competencies

For Customised Template PDF Report:https://www.reporthive.com/request_customization/2525930

Table of Contents

Report Overview:It includes major players of the global Wearable Physical Capacity Evaluation System Market covered in the research study, research scope, and Market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Global Growth Trends:This section focuses on industry trends where market drivers and top market trends are shed light upon. It also provides growth rates of key producers operating in the global Wearable Physical Capacity Evaluation System Market. Furthermore, it offers production and capacity analysis where marketing pricing trends, capacity, production, and production value of the global Wearable Physical Capacity Evaluation System Market are discussed.

Market Share by Manufacturers:Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Market Size by Type:This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application:Besides an overview of the global Wearable Physical Capacity Evaluation System Market by application, it gives a study on the consumption in the global Wearable Physical Capacity Evaluation System Market by application.

Production by Region:Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region:This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Company Profiles:Almost all leading players of the global Wearable Physical Capacity Evaluation System Market are profiled in this section. The analysts have provided information about their recent developments in the global Wearable Physical Capacity Evaluation System Market, products, revenue, production, business, and company.

Market Forecast by Production:The production and production value forecasts included in this section are for the global Wearable Physical Capacity Evaluation System Market as well as for key regional markets.

Market Forecast by Consumption:The consumption and consumption value forecasts included in this section are for the global Wearable Physical Capacity Evaluation System Market as well as for key regional markets.

Value Chain and Sales Analysis:It deeply analyzes customers, distributors, sales channels, and value chain of the global Wearable Physical Capacity Evaluation System Market.

Key Findings: This section gives a quick look at important findings of the research study.

About Us:Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SMEs, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc. This large collection of insightful reports assists clients to stay ahead of time and competition. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales and revenue, technology trends, competitive analysis, product portfolio, and application analysis, etc.

Contact Us:

Report Hive Research

500, North Michigan Avenue,

Suite 6014,

Chicago, IL 60611,

United States

Website: https://www.reporthive.com

Email: [emailprotected]

Phone: +1 312-604-7084

Continued here:
Global Wearable Physical Capacity Evaluation System Market Competitive Environment, Growth Drivers, Validation and Segmentation By 2026|| Hocoma,...

Global Fumaric Acid Market Analysis Of Key Players, Type, Application, Business Trends, Services, Demand And Consumption By 2024 – PRnews Leader

Posted on by

The Fumaric Acid Market study describes the current market size and market forecast, market prospects, main drivers and constraints, regulatory scenario, industry trend, PESTLE analysis, PORTER analysis, new product approvals / launch, promotion and marketing campaigns, pricing analysis , competitive environment to assist companies in decision-making. The data from the study is focused on current and historical market dynamics that assist in decisions related to investment.

Fumaric Acid offers fundamental industry overview representing market trends, company profiles, growth drivers, market scope and Fumaric Acid size estimation. The valuable Fumaric Acid industry insights, type, application, deployment status and research regions are studied. A thorough analysis of gross margin view, trade news, industry plans and policies, constraints are explained. A complete Fumaric Acid industry scenario is explained from 2014 to 2019 and forecast estimates are presented from 2020-2024. The productions, industry chain analysis, gross margin structure and deployment models are stated in detail. Top regions analysed in the report include North America, South America, Europe, Asia-Pacific, Middle East & Africa and the rest of the world. The Fumaric Acid industry presence and maturity analysis will lead to investment feasibility and development scope.

Get A Free Sample Copy Here:

https://www.globalmarketers.biz/report/chemicals-and-materials/global-fumaric-acid-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/131901#request_sample

Fumaric Acid Market Leading Players (2019-2024):

Yantai Hengyuan BioengineeringBartek IngredientsPolyntThirumalai ChemicalIsegenFuso ChemicalsJiangsu Jiecheng BioengineeringChangzhou Yabang ChemicalNIPPON SHOKUBAISealong BiotechnologyChangmao Biochemical EngineeringSuzhou Youhe Science and TechnologyXST Biological

Market Segment Analysis

By Types:

Food-GradeTechnical-Grade

By Applications:

Food & BeveragesRosin Paper SizesUnsaturated Polyester ResinAlkyd ResinsOthers

By Region

North America

Europe

Asia-Pacific

LAMEA

Ask for Discount @:

https://www.globalmarketers.biz/discount_inquiry/discount/131901

Fumaric Acid Industry Report addresses different regions like North America, Europe, Asia-Pacific, Middle East & Africa and Latin America. The production value, gross margin analysis, development trend, and Fumaric Acid market positioning is explained. The industrial chain study, potential buyers, distributors and traders details are explained. The challenges to the growth and market restraints are explained. The market maturity study, investment scope and gross margin study are profiled. The production process structure, market share, manufacturing cost and Fumaric Acid saturation analysis is covered. This will helps the industry aspirants to analysis growth feasibility and development plans.

A special highlight on cost structure, import-export scenario and sales channels of Fumaric Acid industry is presented. The benchmarking products, dynamic market changes, upstream raw material and downstream buyers analysis are presented. The business trends, key players analysis and product segment study are explained. The regional SWOT analysis, gross margin analysis, application analysis and industry barriers are explained. The value, volume and consumption from 2019-2024 is portrayed. All the essential details like pricing structure of raw materials, labour cost, sales channels and downstream buyers are presented.

Inquire Before Buying Or Ask For Custom Requirement:

https://www.globalmarketers.biz/report/chemicals-and-materials/global-fumaric-acid-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/131901#inquiry_before_buying

In the next segment, the forecast Fumaric Acid industry perspective is covered. Under forecast statistics, the market value, volume and consumption forecast from 2019-2024 is explained. Fumaric Acid regional analysis for major regions and countries in this region is stated. The study of new Fumaric Acid industry aspirants and analysts opinions for this industry is presented. The limitations to the industry growth, market risks, Fumaric Acid growth opportunities and market trends are viewed. The revenue, Fumaric Acid market status, past market performance and product details are presented.

Salient Features Of The Report:

The Fumaric Acid report serves as a vital guide in portraying present and forecast industry statistics and market size. The supply/ demand situation, gross margin view and competitive profile of top Fumaric Acid players are presented. The Fumaric Acid market breakdown by product, type, application and regions will provide sophisticated and precise analysis. Recent developments in Fumaric Acid industry, growth opportunities, constraints are studied completely. Also, new product launch events, mergers & acquisitions of Fumaric Acid, and industry plans and policies are covered.

The revenue estimates of Fumaric Acid market based on top industry players, their product type, applications and regions is studied. The cost structures, gross margin view, sales channel analysis and value chain is explained. In the next segment, the SWOT analysis of players, cost structures, traders, distributors and dealers are listed. The forecast study on Fumaric Acid industry will be useful for business plans and growth analysis.

To know More Details About Fumaric Acid Market research Report @:

https://www.globalmarketers.biz/report/chemicals-and-materials/global-fumaric-acid-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/131901#table_of_contents

Contact Us:

Name: Alex White

Phone: US: +1(806)4400782/ UK: +44 33 3303 4979

Email: [emailprotected]

Read this article:
Global Fumaric Acid Market Analysis Of Key Players, Type, Application, Business Trends, Services, Demand And Consumption By 2024 - PRnews Leader

Global Fumaric Acid (Cas 110-17-8) Market 2020 Research : Detailed analysis of the Growth and other Aspects till 2026 – PRnews Leader

Posted on by

Global Fumaric Acid (Cas 110-17-8) Market Report describes the basic elements of the industry and market stats, the recent advances in technology, business plans, policies, possibilities for development and risks to the sector are being described. The two key segments of the report, namely market revenue in (USD Million) and market size (k MT) are presented in this report. The Scope of Fumaric Acid (Cas 110-17-8) industry, market concentration and presence across various region are described in detail.

The prominent Fumaric Acid (Cas 110-17-8) industry players are covered in the next section, their business profiles, product information, and market size. Also, the SWOT analysis of these players, business plans & strategies are covered. It covers the product definition, classification, type and price structures.

Request for Free Sample Report @:

https://www.globalmarketers.biz/report/chemicals-and-materials/global-fumaric-acid-(cas-110-17-8)-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/153566#request_sample

Major players covered in this report:

IsegenThirumalai ChemicalJiangsu Jiecheng BioengineeringSuzhou Youhe Science and TechnologyPolyntFuso ChemicalsSealong BiotechnologyChangzhou Yabang ChemicalYantai Hengyuan BioengineeringNIPPON SHOKUBAIBartek IngredientsChangmao Biochemical EngineeringXST Biological

Market Segmentation:

By Type:

Technical GradeFood Grade

By Application:

Food and Beverage IndustryUnsaturated PolyesterOthers

Get Best Discount on purchasing this report, Ask Here for Discount @:

https://www.globalmarketers.biz/discount_inquiry/discount/153566

In this report Fumaric Acid (Cas 110-17-8) manufacturing value and growth rate from 2015-2019 will be provided at regional level. The nitty gritty evaluation of segments and sub-segments of emerging industries are clerified. It covers Fumaric Acid (Cas 110-17-8) industry plans & policies, financial status, cost structures and analyzes of the value chain. The Fumaric Acid (Cas 110-17-8) competitive perspective of the countryside, the production base, the evaluation of the production method and the upstream raw materials are assessed.

The gross margin, consumption pattern, growth rate of Fumaric Acid (Cas 110-17-8) is studied precisely. The top industry players are covered on a regional level and country level with the analysis of their revenue share from 2015-2019. Furthermore, forecast Fumaric Acid (Cas 110-17-8) industry status is determined by analysis of expected market share, volume, value and development rate. The forecast Fumaric Acid (Cas 110-17-8) industry view is presented from 2020-2026.

Enquire For Complete Sample Report Copy Or Request For Customization:

https://www.globalmarketers.biz/report/chemicals-and-materials/global-fumaric-acid-(cas-110-17-8)-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/153566#inquiry_before_buying

Table of Contents:

Global Fumaric Acid (Cas 110-17-8) Market Size, Status and Forecast 2026

1 Fumaric Acid (Cas 110-17-8) Industry Overview

2 Fumaric Acid (Cas 110-17-8) Competition Analysis by Players

3 Company (Top Players) Profiles

4 Global Fumaric Acid (Cas 110-17-8) Market Size by Type and Application (2015-2019)

5 United States Fumaric Acid (Cas 110-17-8) Development Status and Outlook

6 EU Fumaric Acid (Cas 110-17-8) Development Status and Outlook

7 Japan Fumaric Acid (Cas 110-17-8) Development Status and Outlook

8 Fumaric Acid (Cas 110-17-8) Manufacturing Cost Analysis

9 India Fumaric Acid (Cas 110-17-8) Development Status and Outlook

10 Southeast Asia Fumaric Acid (Cas 110-17-8) Development Status and Outlook

11 Market Forecast by Regions, Type and Application (2020-2026)

12 Fumaric Acid (Cas 110-17-8) Market Dynamics

12.1 Fumaric Acid (Cas 110-17-8) Industry News

12.2 Fumaric Acid (Cas 110-17-8) Industry Development Challenges

12.3 Fumaric Acid (Cas 110-17-8) Industry Development Opportunities (2020-2026)

13 Market Effect Factors Analysis

14 Global Fumaric Acid (Cas 110-17-8) Market Forecast (2020-2026)

15 Research Finding/Conclusion

16 Appendix

Explore Detailed Table Of Content With Table Of Figures: @

https://www.globalmarketers.biz/report/chemicals-and-materials/global-fumaric-acid-(cas-110-17-8)-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/153566#table_of_contents

Read more from the original source:
Global Fumaric Acid (Cas 110-17-8) Market 2020 Research : Detailed analysis of the Growth and other Aspects till 2026 - PRnews Leader

Global Feed Grade Fumaric Acid Market 2020: by Key Players,Regions, Type and Application, Forecast to 2025 – The Think Curiouser

Posted on by

The study on Global Feed Grade Fumaric Acid Market, offers deep insights about the Feed Grade Fumaric Acid Market covering all the crucial aspects of the Market. Some of the important aspects analyzed in the report includes Market share, production, key regions, revenue rate as well as key players. This Feed Grade Fumaric Acid report also provides the readers with detailed figures at which the Feed Grade Fumaric Acid Market was valued in the historical year and its expected growth in upcoming years. Besides, analysis also forecasts the CAGR at which the Feed Grade Fumaric Acid is expected to mount and major factors driving Markets growth. This Feed Grade Fumaric Acid Market was accounted for USD million in the historical year and is estimated to reach at USD million by the end of the forecast period, rising at a CAGR .

Major companies of this report:

Bartek IngredientsPolynt GroupThirumalai ChemicalIsegenFuso ChemicalsNippon ShokubaiYantai Hengyuan BioengineeringJiangsu Jiecheng BioengineeringChangzhou Yabang ChemicalAnhui Sealong BiotechnologyChangmao Biochemical EngineeringSuzhou Youhe Science and TechnologyZhejiang Dongda Biological TechnologyChina Blue Star Harbin PetrochemicalJiangsu Suhua GroupJiaoda Rising Weinan ChemicalChina BBCA Group

Request a sample of this report @ https://www.orbisresearch.com/contacts/request-sample/5028673?utm_source=Ancy

Market research reports play an extremely important role in refining the productivity of an industry. The information in this reports will help the companies to make informed Marketing strategies. Moreover, ultimate goal of Market research is to analyze how the Markets target group will obtain a product or service. Market research report is predominantly prepared following certain methodology and guidelines for collecting, organizing and analyzing data. The research report on Global Feed Grade Fumaric Acid Market has been very well drafted for the benefit of the readers who are looking forward to invest in the Market.

Besides, focusing on overall aspects of the Market this report majorly covered profiles of the top big companies along with their sales data, etc. It also delivers the business models, strategies, growth, innovations and every information about key manufacturers that will enable in making business estimates. In addition, every Market has a set of manufacturers, vendors and consumers that define the Market as well as their every moves and achievements becomes a subject of studying for Market analysts.

Browse the complete report @ https://www.orbisresearch.com/reports/index/2015-2025-global-feed-grade-fumaric-acid-market-research-by-type-end-use-and-region?utm_source=Ancy

Segmentation by Type:

Purity: 99.5%Others

Segmentation by Application:

PoultrySwineRuminantOthers

Moreover, reports offers Market competition through region segmentation of Markets that enables in thorough analysis of the Market in terms of revenue generation potential, demand & supply comparison, business opportunities and future estimates of the Market. The annual progression for the Global Feed Grade Fumaric Acid Market in different regions cannot always be listed down as it will keep changing, thus studying and reviewing Markets occasionally becomes vital. Major regions highlighted for the Global Feed Grade Fumaric Acid Market report, include North America, South America, Asia, Europe and Middle East.

Market research report on the Global Feed Grade Fumaric Acid Market, also has the Market analyzed on the basis of different end user applications and type. End user application segments analysis allows defining the consumer behavior as well. It is helpful to investigate product application in order to foretell the products outcome. Analyzing different segment type is also crucial aspect. It helps determine which type of the product or service needs improvement. When reports are product centric, they also includes information about sales channel, distributors, traders as well as dealers. This facilitates effective planning as well as execution of the supply chain management. In a nutshell, a Market research report is through guide of a Market that aids the better Marketing and management of businesses.

Make an enquiry of this report @ https://www.orbisresearch.com/contacts/enquiry-before-buying/5028673?utm_source=Ancy

About Us :

ABOUT US:Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us :

CONTACT US:Hector CostelloSenior Manager Client Engagements4144N Central Expressway,Suite 600, Dallas,Texas 75204, U.S.A.Phone No.: +1 (972)-362-8199; +91 895 659 5155

Read more:
Global Feed Grade Fumaric Acid Market 2020: by Key Players,Regions, Type and Application, Forecast to 2025 - The Think Curiouser

Clemson Continues to Lead on COVID-19 Testing, Expands Saliva-Based Capacity University received portion of $16.7 million commitment from State of…

Posted on by

Clemson Universitys robust testing strategy has been supplemented this week by additional capacity through saliva-based testing. In the three days of expanded saliva testing, the University has processed 1,599 tests, with 95% of results being returned the same day of the test.

The recent development of a laboratory certified by the Clinical Laboratory Improvement Amendments commonly called a CLIA Lab based in Jordan Hall on the main university campus has facilitated the increase in capacity. The University received a commitment of $6.9 million through Governor Henry McMaster and the States Joint Bond Review Committee to assist in the development and expansion of the CLIA Lab.

This funding provides the additional high capacity lab facilities, testing support and reporting resources to help Clemson University meet its obligations to its students, faculty and staff and further its Land Grant Mission of helping the State of South Carolina, Clemson University President Jim Clements said. Clemsons continued partnerships and collaborations with the other research universities across the state as well as its close working relationship with SC-DHEC will further the state and our communitys response to this pandemic.The goal of the CLIA labs is to 1) provide regular, rapid testing of Clemson faculty, staff, and students and 2) collaborate with DHEC to expand and facilitate rapid testing availability for the entire Upstate community and other institutions of higher education throughout the State.

Collaboration between Clemsons new CLIA labs and DHEC will help fight community spread through expanding availability of faster, less-invasive saliva-based tests to off-campus Clemson students, local school districts, and other members of the Upstate community.

Overseen by Delphine Dean, the Ron and Jane Lindsay Professor of Bioengineering, with the help of Mark Blenner, the McQueen Quattlebaum Associate Professor of Chemical Engineering, the lab employs 20 graduate students serving as the labs technicians. Approximately 30 undergraduates are helping with sample collection and are training in data handling and other tasks to assist the technicians.

When fully operational, the lab will be able to test 5,000 samples daily and return results the same day.

This is a multidisciplinary, University-wide effort to create a lab that is a cutting-edge solution to help fight COVID-19, Dean said. Were trying to ramp up quickly but safely.

Angie Leidinger, Clemsons vice president for External Affairs, said the lab is an example of the ingenuity that researchers are showing in the face of a global pandemic that is unprecedented in modern times.

Were grateful to Governor McMaster and the JBRC for this investment, Leidinger said. This funding not only assists in the immediate needs related to COVID, but also positions Clemson and the State of South Carolina to be a leader in competitive health-related research grants in the future.

Here is the original post:
Clemson Continues to Lead on COVID-19 Testing, Expands Saliva-Based Capacity University received portion of $16.7 million commitment from State of...

Two Penn Med professors win total of $8 million in grants from National Institutes of Health – The Daily Pennsylvanian

Posted on by

The Perelman School of Medicine's Brian Litt (left) and Gregory Corder (right) were awarded Directors Awards from the National Institutes of Health.

The National Institutes of Health awarded its Director's Awards, which include a combined $8 million in research grants to two professors at Penns Perelman School of Medicine.

Brian Litt, a professor of neurology, neurosurgery, and bioengineering, and Gregory Corder, an assistant professor of neuroscience and psychiatry, are two of this year's 85 recipients, Penn Medicine News reported.

The awards are part of the NIH Common Fund's "High-Risk, High Reward Research Program," which aims to "fuel research endeavors that are more open-ended and could have a broader effect on scientific understanding than traditional research." Corder was awarded the New Innovator Award, receiving $2.4 million to investigate the mechanisms of chronic pain, and Litt was awarded the Pioneer Award for $5.6 million which will support his novel neurodevice research.

Litt is working to develop autonomous neurodevices, or "implanted machines that can question, record, and combine learning algorithms based on neurological signals and feedback to act and alter human behavior on the fly," Penn Medicine News reported.

For patients with epilepsy, the devices would predict and prevent seizures. In Parkinson's patients, implants would communicate with patients to improve mobility, reduce tremors, and enhance responsiveness.

Corder plans to use the grant to "identify which parts of the brain are important for pain perception and which circuits impact pain relief from opioids," Penn Medicine News reported.

In the wake of widespread opioid addiction that has increased over the past decade, this research can pave the way for effective pain-relief treatment without the addictive properties of opioids.

We currently have a limited understanding of the neural pathways in the brain that contribute to pain, which has been a significant barrier for treating pain efficiently, without negative side effects," Corder told Penn Medicine News. "But, if we can identify and understand these circuits, we can then try to rewrite the neural code of pain.

Read the original:
Two Penn Med professors win total of $8 million in grants from National Institutes of Health - The Daily Pennsylvanian

Missouri S&T News and Events Missouri S&T professor elected as ASEM Fellow – Missouri S&T News and Research

Posted on by

Dr. Steven Corns, associate chair of graduate studies and associate professor of engineering management and systems engineering at Missouri S&T, has been elected to the 2020 class of fellows of the American Society for Engineering Management (ASEM).

Ive enjoyed the privilege of serving with Steve over the last three years in his collaborative research with faculty at the United States Military Academy (USMA) department of systems engineering (DSE), and in his leadership to ASEM, says USMA Lt. Col. James Schreiner, one of Corns nominators. His expert advice as a committee member for three senior DSE faculty and insights offered as a member of the board of advisors has greatly enhanced technical skills and strategic initiatives within the West Point department.

Corns is active in ASEM as well as the Institute of Industrial and Systems Engineers. He has served as chair of the Bioinformatics and Bioengineering Technical Committee for the Computational Intelligence Society of the Institute of Electrical and Electronics Engineers (IEEE) and represents the IEEE Computational Intelligence Society as chair for the Greater St. Louis Area. Corns served as the lead investigator for the Model-based Systems Engineering Initiative Biomedical Challenge Team of the International Council on Systems Engineering.

I am truly honored to have been selected as a fellow of the American Society of Engineering Management, says Corns. ASEM is the strongest organization for the engineering management profession, providing guidance and support to practicing engineering managers for decades. I look forward to the opportunity to carry on this tradition of excellence and to help keep moving the society and profession forward.

Corns is an investigator in the Environmental Research Center for Emerging Contaminants and the Energy Research and Development Center at Missouri S&T and is affiliated with the Intelligent Systems Center. He joined the faculty at Missouri S&T in 2008.

About Missouri University of Science and Technology

Founded in 1870 as the University of Missouri School of Mines and Metallurgy, Missouri University of Science and Technology (Missouri S&T) is a STEM-focused research university of more than 8,000 students and part of the four-campus University of Missouri System. Located in Rolla, Missouri S&T offers 99 different degree programs in 40 areas of study, including engineering, the sciences, business and information technology, the humanities, and the liberal arts. Missouri S&T is known globally and is highly ranked for providing a high return on tuition investment, exceptional career opportunities for graduates, and an emphasis on applied, hands-on learning through student design teams and cooperative education and internship opportunities. For more information about Missouri S&T, visit mst.edu.

More:
Missouri S&T News and Events Missouri S&T professor elected as ASEM Fellow - Missouri S&T News and Research

Vanderbilt researchers develop publicly available COVID-19 animal susceptibility prediction tool; suggests increased risk to horses – Vanderbilt…

Posted on by

A Vanderbilt team of experts in virology, genetics, structural biology, chemistry, physiology, medicine, immunology and pharmacology have together developed technology to understand and predict animal susceptibility to SARS-CoV-2, the scientific name for the strain of coronavirus causing COVID-19. providing evidence that horses and camels may be at increased risk of the virus. The group has also released a publicly available tool to enable people to understand the likelihood of other animals susceptibility.

The article, Predicting susceptibility to SARS-CoV-2 infection based on structural differences in ACE2 across species, was published in the Federation of American Societies for Experimental Biology (FASEB) Journal on Oct. 5.

The investigators applied a combination of sophisticated genetic sequence alignment and structural analysis of ACE2, the receptor protein for SARS-CoV-2, to a variety of known susceptible and non-susceptible species. Through the analysis they identified five particular amino acid sites within the protein that distinguish virus susceptibility or resistance, and using these sites developed an algorithm to predict susceptibility of unknown species. The algorithm has been made public on a website where people can upload the aligned ACE2 sequence of animals with unknown susceptibility to generate a COVID-19 susceptibility score.

Jacquelyn Brown, a staff scientist at the Vanderbilt Institute for Integrative Biosystems Research and Education, initiated the project. When I first learned that COVID-19 had crossed the species barrier into cats and dogs, I became worried about other animals that might act as reservoirs for the disease or be at risk, explained Brown, an avid equestrian who practices medieval mounted archery. Since MERS infects camels, I was concerned about what would happen if my horse could get it?! Horses have massive lungs and a sensitive respiratory system, and we humans often touch their noses and mouths.

206,000 horses live on horse farms and properties in Tennessee and 3.2 million of the states 10 million farm acres are devoted to the horse industry. Brown proposed a collaborative research project on the topic to Gordon A. Cain University Professor John Wikswo, who holds appointments in physics, biomedical engineering, and molecular physiology and biophysics.

As the director of VIIBRE, an institute established to foster and enhance interdisciplinary research in the biophysical sciences, bioengineering and medicine at Vanderbilt, Wikswo immediately assembled a trans-institutional team spanning Vanderbilt schools and colleges and Vanderbilt University Medical Center. I speak each disciplines language well enough to make the necessary connections, Wikswo said. This proved to be an outstanding group brought together by their interests and skills that produced an important result in very short order.

The project gave meaning to each researcher, at a time when we all were searching for ways to contribute to fighting COVID-19, noted Wenbiao Chen.

The work could not have been achieved without the collaboration of many researchers. The multidisciplinary approach revealed how much information can be wrung from the same basic information, noted Wenbiao Chen, the papers co-corresponding author and associate professor of molecular physiology and biophysics. We found potential targets by sequence comparison but wouldnt have been able to interpret our findings without structural information. The project gave meaning to each researcher, at a time when we all were searching for ways to contribute to fighting COVID-19.

Understanding the animals we should more closely scrutinize based on their susceptibility to COVID-19 can help us protect people, pets, wildlife, livestock and our food sources, said Matthew Alexander, assistant professor of medicine. The algorithm the team developed is particular to SARS-CoV-2 because it focuses on its particular receptor binding protein ACE2, but the approach is broadly applicable to predicting susceptibility to other viruses or during future outbreaks.

There is also the opportunity to investigate if the identified five sites on ACE2 that most distinguish susceptible from non-susceptible species can be used as targets to develop drugs that inhibit these sites specifically. I hope that our results will inspire future research on both rational drug design and closer examination of at-risk species, said Meena Madhur, the papers co-corresponding author, associate professor of medicine and associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation at VUMC.

Of note, the work and collaboration were conducted remotely, with an analysis of publicly available data. This experimental approach of using extensive and rapidly accumulating publicly available data in new ways allowed us to efficiently answer a timely question without having to generate new datasets. The collaboration was fun and rewarding, and we were able to answer an important question that none of us could have solved alone, Alexander, the papers co-first author said. Wikswo pointed out that while the source data was public, the project required massive calculations of how different versions of the virus would bind to each animals ACE2.

Members of the collaborative project also include Distinguished Research Professor of Chemistry Jens Meiler, Clara Schoeder, co-first author and postdoctoral scholar, , Charles Duncan Smart, graduate student in molecular physiology and biophysics, Chris Moth, computational chemist in the biological sciences department, and Tony Capra, research associate professor of biological sciences.

The work was supported by National Institutes of Health grants F32HL144048-01, DK117147, UH3TR002097 and U01TR002383, U19AI117905, U01AI150739, and R01AI141661, R35GM127087, and DP2HL137166 and American Heart Association grants 20PRE35080177 and EIA34480023

Read more:
Vanderbilt researchers develop publicly available COVID-19 animal susceptibility prediction tool; suggests increased risk to horses - Vanderbilt...

Admissions at SCTIMST in Thiruvananthapuram: Apply by October 15 – Mathrubhumi English

Posted on by

");a.close()},docType:function(){return"iframe"==d.mode?"":"html5"==d.standard?"":'oose"==d.standard?" Transitional":"")+'//EN" "//www.w3.org/TR/html4/'+("loose"==d.standard?"loose":"strict")+'.dtd">'},getHead:function(){var a="",b="";d.extraHead&&d.extraHead.replace(/([^,]+)/g,function(b){a+=b});c(document).find("link").filter(function(){var a= c(this).attr("rel");return"undefined"===c.type(a)==0&&"stylesheet"==a.toLowerCase()}).filter(function(){var a=c(this).attr("media");return"undefined"===c.type(a)||""==a||"print"==a.toLowerCase()||"all"==a.toLowerCase()}).each(function(){b+=''});d.extraCss&&d.extraCss.replace(/([^,s]+)/g,function(a){b+=''});return"

"+a+b+""},getBody:function(a){var b= "",f=d.retainAttr;a.each(function(){for(var a=e.getFormData(c(this)),d="",g=0;g"+c(a).html()+""});return""+b+""},getFormData:function(a){var b=a.clone(),d=c("input,select,textarea",b);c("input,select,textarea",a).each(function(a){var b=c(this).attr("type");"undefined"===c.type(b)&&(b=c(this).is("select")?"select":c(this).is("textarea")?"textarea":"");var e=d.eq(a);"radio"==b||"checkbox"==b?e.attr("checked",c(this).is(":checked")):"text"==b?e.attr("value",c(this).val()):"select"==b?c(this).find("option").each(function(a){c(this).is(":selected")&&c("option",e).eq(a).attr("selected",!0)}):"textarea"==b&&e.text(c(this).val())});return b},getPrintWindow:function(){switch(d.mode){case "iframe":var a=new e.Iframe;return{win:a.contentWindow||a,doc:a.doc};case "popup":return a=new e.Popup,{win:a,doc:a.doc}}},Iframe:function(){var a=d.id,b;try{b=document.createElement("iframe"),document.body.appendChild(b), c(b).attr({style:"border:0;position:absolute;width:0px;height:0px;right:0px;top:0px;",id:a,src:"#"+(new Date).getTime()}),b.doc=null,b.doc=b.contentDocument?b.contentDocument:b.contentWindow?b.contentWindow.document:b.document}catch(f){throw f+". iframes may not be supported in this browser.";}if(null==b.doc)throw"Cannot find document.";return b},Popup:function(){var a;a="location=yes,statusbar=no,directories=no,menubar=no,titlebar=no,toolbar=no,dependent=no"+(",width="+d.popWd+",height="+d.popHt); a+=",resizable=yes,screenX="+d.popX+",screenY="+d.popY+",personalbar=no,scrollbars=yes";a=window.open("","_blank",a);a.doc=a.document;return a}}})(jQuery);

Originally posted here:
Admissions at SCTIMST in Thiruvananthapuram: Apply by October 15 - Mathrubhumi English

InnoVision Awards recognize innovation in the Palmetto State – Upstate Business Journal

Posted on by

The InnoVision Awards program announced on Sept. 25 its finalists for this years awards recognizing innovation in South Carolina.

The awards began in 1999 with the mission to highlight, promote and foster innovation in the Upstate, said Amy Robichaud, board chair of the InnoVision Awards.Around 10 years ago, the awards expanded to cover all of South Carolina.

The categories for the awards, Robichaud said, are meant to encompass businesses of all sizes and stages, community organizations and educational institutions.New to this years categories were ones recognizing innovation around confronting COVID-19 that included technology research, technology application and community service.

We thought that we would possibly get some entries related to COVID-19 this year, but it was a very special circumstance, said Robichaud. A lot of companies and organizations were being extremely innovative, pivoting, responding to community needs we thought that it would be a good thing to highlight that with a special category to showcase and celebrate the innovators in South Carolina who really stepped up to the challenge during this crisis.

In the weeks leading up to the winners being announced at a Nov. 17, ceremony, each Tuesday at 4 p.m. InnoVision will host a series of online gatherings to celebrate the finalists. Those began Sept. 29 and will run until Oct. 20. You can sign up for the virtual events at innovisionawards.org.

Aravis Biotech Greenville, SC

Blinktbi Charleston, SC

Techtronic Industries Power Equipment Anderson, SC

Know2 Gaffney, SC

StartME Spartanburg Spartanburg, SC

Union County Library System Union, SC

Agulus Inc. Greenville, SC

Clemson Universitys Composite Center Greenville, SC

Delta Bravo Artificial Intelligence Rock Hill, SC

Clemson Universitys Foam Recycling Center

Sonoco Products Company Hartsville, SC

tForm, Inc. Williamston, SC

Oversight, Inc. Greenville, SC

Stand Yourself Up LLC Anderson, SC

Verifyii Intelligent Identification Greenville, SC

IT-oLogy Columbia, SC

Spartanburg Community College Spartanburg, SC

VR Mondi Clemson, SC

Blue Eye Soft Corp Greer, SC

Hoowaki LLC Greenville, SC

LANCR Health Technologies

Clemson Autonomous Systems Team (Clemson University Mechanical Engineering) Clemson, SC

Negative Pressure Chamber Project (Clemson University Bioengineering) Clemson, SC

Covid Microbead Screening Project (Clemson University Chemistry) Clemson, SC

Covid Biomarker Detection Test Project (Clemson University Bioengineering) Clemson, SC

SaveMAPS Clemson, SC

United Way of the Piedmont Spartanburg, SC

Clemson Universitys Watt Family Innovation Center Clemson, SC

See the original post here:
InnoVision Awards recognize innovation in the Palmetto State - Upstate Business Journal

Analyzing Impacts Of Covid-19 On Laboratory Compressors And Pumps Market Effects, Aftermath And Forecast To 2026 – The Daily Chronicle

Posted on by

Overview for Laboratory Compressors And Pumps Market Helps in providing scope and definitions, Key Findings, Growth Drivers, and Various Dynamics.

Laboratory Compressors And Pumps Market Data and Acquisition Research Study with Trends and Opportunities 2019-2024The study of Laboratory Compressors And Pumps market is a compilation of the market of Laboratory Compressors And Pumps broken down into its entirety on the basis of types, application, trends and opportunities, mergers and acquisitions, drivers and restraints, and a global outreach. The detailed study also offers a board interpretation of the Laboratory Compressors And Pumps industry from a variety of data points that are collected through reputable and verified sources. Furthermore, the study sheds a lights on a market interpretations on a global scale which is further distributed through distribution channels, generated incomes sources and a marginalized market space where most trade occurs.

Along with a generalized market study, the report also consists of the risks that are often neglected when it comes to the Laboratory Compressors And Pumps industry in a comprehensive manner. The study is also divided in an analytical space where the forecast is predicted through a primary and secondary research methodologies along with an in-house model.

Download PDF Sample of Laboratory Compressors And Pumps Market report @ https://hongchunresearch.com/request-a-sample/80224

Key players in the global Laboratory Compressors And Pumps market covered in Chapter 4:Hangzhou Tailin Bioengineering EquipmentsJUN-AIR International A/SGardner DenverHeidolphCoaireGeneral europe vacuumHirschmann

In Chapter 11 and 13.3, on the basis of types, the Laboratory Compressors And Pumps market from 2015 to 2026 is primarily split into:Vacuum pumpsLaboratory peristaltic pumpsCompressorsVacuum systems

In Chapter 12 and 13.4, on the basis of applications, the Laboratory Compressors And Pumps market from 2015 to 2026 covers:Lab Instruments

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:North America (Covered in Chapter 6 and 13)United StatesCanadaMexicoEurope (Covered in Chapter 7 and 13)GermanyUKFranceItalySpainRussiaOthersAsia-Pacific (Covered in Chapter 8 and 13)ChinaJapanSouth KoreaAustraliaIndiaSoutheast AsiaOthersMiddle East and Africa (Covered in Chapter 9 and 13)Saudi ArabiaUAEEgyptNigeriaSouth AfricaOthersSouth America (Covered in Chapter 10 and 13)BrazilArgentinaColumbiaChileOthers

For a global outreach, the Laboratory Compressors And Pumps study also classifies the market into a global distribution where key market demographics are established based on the majority of the market share. The following markets that are often considered for establishing a global outreach are North America, Europe, Asia, and the Rest of the World. Depending on the study, the following markets are often interchanged, added, or excluded as certain markets only adhere to certain products and needs.

Here is a short glance at what the study actually encompasses:Study includes strategic developments, latest product launches, regional growth markers and mergers & acquisitionsRevenue, cost price, capacity & utilizations, import/export rates and market shareForecast predictions are generated from analytical data sources and calculated through a series of in-house processes.

However, based on requirements, this report could be customized for specific regions and countries.

Brief about Laboratory Compressors And Pumps Market Report with [emailprotected] https://hongchunresearch.com/report/laboratory-compressors-and-pumps-market-size-2020-80224

Some Point of Table of Content:

Chapter One: Report Overview

Chapter Two: Global Market Growth Trends

Chapter Three: Value Chain of Laboratory Compressors And Pumps Market

Chapter Four: Players Profiles

Chapter Five: Global Laboratory Compressors And Pumps Market Analysis by Regions

Chapter Six: North America Laboratory Compressors And Pumps Market Analysis by Countries

Chapter Seven: Europe Laboratory Compressors And Pumps Market Analysis by Countries

Chapter Eight: Asia-Pacific Laboratory Compressors And Pumps Market Analysis by Countries

Chapter Nine: Middle East and Africa Laboratory Compressors And Pumps Market Analysis by Countries

Chapter Ten: South America Laboratory Compressors And Pumps Market Analysis by Countries

Chapter Eleven: Global Laboratory Compressors And Pumps Market Segment by Types

Chapter Twelve: Global Laboratory Compressors And Pumps Market Segment by Applications12.1 Global Laboratory Compressors And Pumps Sales, Revenue and Market Share by Applications (2015-2020)12.1.1 Global Laboratory Compressors And Pumps Sales and Market Share by Applications (2015-2020)12.1.2 Global Laboratory Compressors And Pumps Revenue and Market Share by Applications (2015-2020)12.2 Lab Instruments Sales, Revenue and Growth Rate (2015-2020)

Chapter Thirteen: Laboratory Compressors And Pumps Market Forecast by Regions (2020-2026) continued

Check [emailprotected] https://hongchunresearch.com/check-discount/80224

List of tablesList of Tables and FiguresTable Global Laboratory Compressors And Pumps Market Size Growth Rate by Type (2020-2026)Figure Global Laboratory Compressors And Pumps Market Share by Type in 2019 & 2026Figure Vacuum pumps FeaturesFigure Laboratory peristaltic pumps FeaturesFigure Compressors FeaturesFigure Vacuum systems FeaturesTable Global Laboratory Compressors And Pumps Market Size Growth by Application (2020-2026)Figure Global Laboratory Compressors And Pumps Market Share by Application in 2019 & 2026Figure Lab Instruments DescriptionFigure Global COVID-19 Status OverviewTable Influence of COVID-19 Outbreak on Laboratory Compressors And Pumps Industry DevelopmentTable SWOT AnalysisFigure Porters Five Forces AnalysisFigure Global Laboratory Compressors And Pumps Market Size and Growth Rate 2015-2026Table Industry NewsTable Industry PoliciesFigure Value Chain Status of Laboratory Compressors And PumpsFigure Production Process of Laboratory Compressors And PumpsFigure Manufacturing Cost Structure of Laboratory Compressors And PumpsFigure Major Company Analysis (by Business Distribution Base, by Product Type)Table Downstream Major Customer Analysis (by Region)Table Hangzhou Tailin Bioengineering Equipments ProfileTable Hangzhou Tailin Bioengineering Equipments Production, Value, Price, Gross Margin 2015-2020Table JUN-AIR International A/S ProfileTable JUN-AIR International A/S Production, Value, Price, Gross Margin 2015-2020Table Gardner Denver ProfileTable Gardner Denver Production, Value, Price, Gross Margin 2015-2020Table Heidolph ProfileTable Heidolph Production, Value, Price, Gross Margin 2015-2020Table Coaire ProfileTable Coaire Production, Value, Price, Gross Margin 2015-2020Table General europe vacuum ProfileTable General europe vacuum Production, Value, Price, Gross Margin 2015-2020Table Hirschmann ProfileTable Hirschmann Production, Value, Price, Gross Margin 2015-2020Figure Global Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Global Laboratory Compressors And Pumps Revenue ($) and Growth (2015-2020)Table Global Laboratory Compressors And Pumps Sales by Regions (2015-2020)Table Global Laboratory Compressors And Pumps Sales Market Share by Regions (2015-2020)Table Global Laboratory Compressors And Pumps Revenue ($) by Regions (2015-2020)Table Global Laboratory Compressors And Pumps Revenue Market Share by Regions (2015-2020)Table Global Laboratory Compressors And Pumps Revenue Market Share by Regions in 2015Table Global Laboratory Compressors And Pumps Revenue Market Share by Regions in 2019Figure North America Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Europe Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Asia-Pacific Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Middle East and Africa Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure South America Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure North America Laboratory Compressors And Pumps Revenue ($) and Growth (2015-2020)Table North America Laboratory Compressors And Pumps Sales by Countries (2015-2020)Table North America Laboratory Compressors And Pumps Sales Market Share by Countries (2015-2020)Figure North America Laboratory Compressors And Pumps Sales Market Share by Countries in 2015Figure North America Laboratory Compressors And Pumps Sales Market Share by Countries in 2019Table North America Laboratory Compressors And Pumps Revenue ($) by Countries (2015-2020)Table North America Laboratory Compressors And Pumps Revenue Market Share by Countries (2015-2020)Figure North America Laboratory Compressors And Pumps Revenue Market Share by Countries in 2015Figure North America Laboratory Compressors And Pumps Revenue Market Share by Countries in 2019Figure United States Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Canada Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Mexico Laboratory Compressors And Pumps Sales and Growth (2015-2020)Figure Europe Laboratory Compressors And Pumps Revenue ($) Growth (2015-2020)Table Europe Laboratory Compressors And Pumps Sales by Countries (2015-2020)Table Europe Laboratory Compressors And Pumps Sales Market Share by Countries (2015-2020)Figure Europe Laboratory Compressors And Pumps Sales Market Share by Countries in 2015Figure Europe Laboratory Compressors And Pumps Sales Market Share by Countries in 2019Table Europe Laboratory Compressors And Pumps Revenue ($) by Countries (2015-2020)Table Europe Laboratory Compressors And Pumps Revenue Market Share by Countries (2015-2020)Figure Europe Laboratory Compressors And Pumps Revenue Market Share by Countries in 2015Figure Europe Laboratory Compressors And Pumps Revenue Market Share by Countries in 2019Figure Germany Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure UK Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure France Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Italy Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Spain Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Russia Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Asia-Pacific Laboratory Compressors And Pumps Revenue ($) and Growth (2015-2020)Table Asia-Pacific Laboratory Compressors And Pumps Sales by Countries (2015-2020)Table Asia-Pacific Laboratory Compressors And Pumps Sales Market Share by Countries (2015-2020)Figure Asia-Pacific Laboratory Compressors And Pumps Sales Market Share by Countries in 2015Figure Asia-Pacific Laboratory Compressors And Pumps Sales Market Share by Countries in 2019Table Asia-Pacific Laboratory Compressors And Pumps Revenue ($) by Countries (2015-2020)Table Asia-Pacific Laboratory Compressors And Pumps Revenue Market Share by Countries (2015-2020)Figure Asia-Pacific Laboratory Compressors And Pumps Revenue Market Share by Countries in 2015Figure Asia-Pacific Laboratory Compressors And Pumps Revenue Market Share by Countries in 2019Figure China Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Japan Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure South Korea Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Australia Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure India Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Southeast Asia Laboratory Compressors And Pumps Sales and Growth Rate (2015-2020)Figure Middle East and Africa Laboratory Compressors And Pumps Revenue ($) and Growth (2015-2020) continued

About HongChun Research:HongChun Research main aim is to assist our clients in order to give a detailed perspective on the current market trends and build long-lasting connections with our clientele. Our studies are designed to provide solid quantitative facts combined with strategic industrial insights that are acquired from proprietary sources and an in-house model.

Contact Details:Jennifer GrayManager Global Sales+ 852 8170 0792[emailprotected]

NOTE: Our report does take into account the impact of coronavirus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.

As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.

More:
Analyzing Impacts Of Covid-19 On Laboratory Compressors And Pumps Market Effects, Aftermath And Forecast To 2026 - The Daily Chronicle

The Geographic Bias in Medical AI Tools – Stanford University News

Posted on by

Just a few decades ago, scientists didnt think much about diversity when studying new medications. Most clinical trials enrolled mainly white men living near urban research institutes, with the assumption that any findings would apply equally to the rest of the country. Later research demonstrated that assumption to be false; examples accumulated of medications that were later determined to be less effective or caused more side effects in populations that were underrepresented in the initial study.

To address these inequities, federal requirements for participation in medical research were broadened in the 1990s, and clinical trials now attempt to enroll diverse populations from the onset of the study.

But we are now at risk of repeating these same mistakes as we develop new technologies, such as AI. Researchers from Stanford University examined clinical applications of machine learning to find that most algorithms are trained on datasets from patients in only three geographic areas, and that the majority of states have no represented patients whatsoever.

AI algorithms should mirror the community, says Amit Kaushal, an attending physician at VA Palo Alto Hospital and Stanford adjunct professor of bioengineering. If were building AI-based tools for patients across the United States, as a field, we cant have the data to train these tools all coming from the same handful of places.

Kaushal, along with Russ Altman, a Stanford professor of bioengineering, genetics, medicine, and biomedical data science, and Curt Langlotz, a professor of radiology and biomedical informatics research, examined five years of peer-reviewed articles that trained a deep-learning algorithm for a diagnostic task intended to assist with patient care. Among U.S. studies where geographic origin could be characterized, they found the majority (71%) used patient data from California, Massachusetts, or New York to train the algorithms. Some 60% solely relied on these three locales. Thirty-four states were not represented at all, while the other 13 states contributed limited data.

The research didnt expose bad outcomes from AI trained on the geographies, but raised questions about the validity of the algorithms for patients in other areas. We need to understand the impact of these biases and whether considerable investments should be made to remove them, says Altman, associate director of the Stanford Institute for Human-Centered Artificial Intelligence.

Geography correlates to a zillion things relative to health, Altman says. It correlates to lifestyle and what you eat and the diet you are exposed to; it can correlate to weather exposure and other exposures depending on if you live in an area with fracking or high EPA levels of toxic chemicals all of that is correlated with geography.

If these datasets were used for an algorithm to diagnose patients across the United States, you could be doing actual harm to the people not included in the sample.

Limited data also means limited vision. The data you have available impacts the problems you can study in the first place, Kaushal says. If I only have access to data from California, Massachusetts, and New York, I can build algorithms to help people in those places. But problems that are more common in other geographies wont even be on my radar.

The takeaways from this study: Larger and more diverse datasets are needed for the development of innovative AI algorithms. Stanford has led the way in making diagnostic datasets freely available for science more than any other center by far, says Langlotz, director of the Stanford Center for Artificial Intelligence in Medicine and Imaging. But its expensive and its not enough. Resources are needed to help centers across the country contribute to more diverse training datasets.

The public also should be skeptical when medical AI systems are developed from narrow training datasets. And regulators must scrutinize the training methods for these new machine learning systems.

Medicine has been down this road before early clinical trials didnt think much about gender, racial, or geographic diversity and we are still working to address that oversight, Kaushal says. As AI is set to enter clinical medicine, we shouldnt have to wait 30, 40 years to make all the same mistakes and fix them again. We should see where this is headed and address it upfront.

Stanford HAI's mission is to advance AI research, education, policy and practice to improve the human condition.Learn more.

See more here:
The Geographic Bias in Medical AI Tools - Stanford University News

Hesperidin Market size was US$ 81 million and it is expected to reach US$ 125.2 million by the end of 2026, with a CAGR of 6.3% – The Daily Chronicle

Posted on by

LOS ANGELES, United States: QY Research has recently published a research report titled, Global Hesperidin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026. This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Hesperidin market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the global Hesperidin market.

The report includes CAGR, market shares, sales, gross margin, value, volume, and other vital market figures that give an exact picture of the growth of the global Hesperidin market.

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Hesperidin market.

Key questions answered in the report:

TOC

1 Study Coverage1.1 Hesperidin Product Introduction1.2 Market by Type1.2.1 Global Hesperidin Market Size Growth Rate by Type1.2.2 90%-92% Type1.2.3 93%-98% Type1.2.4 Others1.3 Market by Application1.3.1 Global Hesperidin Market Size Growth Rate by Application1.3.2 Pharmaceutical Intermediates1.3.3 Food Industry1.4 Study Objectives1.5 Years Considered 2 Executive Summary2.1 Global Hesperidin Market Size Estimates and Forecasts2.1.1 Global Hesperidin Revenue 2015-20262.1.2 Global Hesperidin Sales 2015-20262.2 Hesperidin Market Size by Region: 2020 Versus 20262.3 Hesperidin Sales by Region (2015-2026)2.3.1 Global Hesperidin Sales by Region: 2015-20202.3.2 Global Hesperidin Sales Forecast by Region (2021-2026)2.3.3 Global Hesperidin Sales Market Share by Region (2015-2026)2.4 Hesperidin Market Estimates and Projections by Region (2021-2026)2.4.1 Global Hesperidin Revenue by Region: 2015-20202.4.2 Global Hesperidin Revenue Forecast by Region (2021-2026)2.4.3 Global Hesperidin Revenue Market Share by Region (2015-2026) 3 Global Hesperidin by Manufacturers3.1 Global Top Hesperidin Manufacturers by Sales3.1.1 Global Hesperidin Sales by Manufacturer (2015-2020)3.1.2 Global Hesperidin Sales Market Share by Manufacturer (2015-2019)3.2 Global Top Hesperidin Manufacturers by Revenue3.2.1 Global Hesperidin Revenue by Manufacturer (2015-2020)3.2.2 Global Hesperidin Revenue Share by Manufacturer (2015-2020)3.3 Global Hesperidin Price by Manufacturer (2015-2020)3.4 Competitive Landscape3.4.1 Key Hesperidin Manufacturers Covered: Ranking by Revenue3.4.2 Global Hesperidin Market Concentration Ratio (CR5 and HHI) & (2015-2020)3.4.3 Global Hesperidin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.5 Global Hesperidin Manufacturing Base Distribution, Product Type3.5.1 Hesperidin Manufacturers Manufacturing Base Distribution, Headquarters3.5.2 Manufacturers Hesperidin Product Type3.5.3 Date of International Manufacturers Enter into Hesperidin Market3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Company Profiles4.1 Zhejiang Conler Pharmaceutical4.1.1 Zhejiang Conler Pharmaceutical Corporation Information4.1.2 Zhejiang Conler Pharmaceutical Description, Business Overview4.1.3 Zhejiang Conler Pharmaceutical Hesperidin Products Offered4.1.4 Zhejiang Conler Pharmaceutical Hesperidin Sales, Revenue and Gross Margin (2015-2020)4.1.5 Zhejiang Conler Pharmaceutical Hesperidin Revenue by Product4.1.6 Zhejiang Conler Pharmaceutical Hesperidin Revenue by Application4.1.7 Zhejiang Conler Pharmaceutical Hesperidin Revenue by Geographic Area4.1.8 Zhejiang Conler Pharmaceutical Hesperidin Revenue by Sales Channel4.1.9 Zhejiang Conler Pharmaceutical Recent Development4.2 Chengdu Okay4.2.1 Chengdu Okay Corporation Information4.2.2 Chengdu Okay Description, Business Overview4.2.3 Chengdu Okay Hesperidin Products Offered4.2.4 Chengdu Okay Hesperidin Sales, Revenue and Gross Margin (2015-2020)4.2.5 Chengdu Okay Hesperidin Revenue by Product4.2.6 Chengdu Okay Hesperidin Revenue by Application4.2.7 Chengdu Okay Hesperidin Revenue by Geographic Area4.2.8 Chengdu Okay Hesperidin Revenue by Sales Channel4.2.9 Chengdu Okay Recent Development4.3 Sichuan Deebio Pharmaceutical4.3.1 Sichuan Deebio Pharmaceutical Corporation Information4.3.2 Sichuan Deebio Pharmaceutical Description, Business Overview4.3.3 Sichuan Deebio Pharmaceutical Hesperidin Products Offered4.3.4 Sichuan Deebio Pharmaceutical Hesperidin Sales, Revenue and Gross Margin (2015-2020)4.3.5 Sichuan Deebio Pharmaceutical Hesperidin Revenue by Product4.3.6 Sichuan Deebio Pharmaceutical Hesperidin Revenue by Application4.3.7 Sichuan Deebio Pharmaceutical Hesperidin Revenue by Geographic Area4.3.8 Sichuan Deebio Pharmaceutical Hesperidin Revenue by Sales Channel4.3.9 Sichuan Deebio Pharmaceutical Recent Development4.4 Hunan Kang Biotech4.4.1 Hunan Kang Biotech Corporation Information4.4.2 Hunan Kang Biotech Description, Business Overview4.4.3 Hunan Kang Biotech Hesperidin Products Offered4.4.4 Hunan Kang Biotech Hesperidin Sales, Revenue and Gross Margin (2015-2020)4.4.5 Hunan Kang Biotech Hesperidin Revenue by Product4.4.6 Hunan Kang Biotech Hesperidin Revenue by Application4.4.7 Hunan Kang Biotech Hesperidin Revenue by Geographic Area4.4.8 Hunan Kang Biotech Hesperidin Revenue by Sales Channel4.4.9 Hunan Kang Biotech Recent Development4.5 Sichuan Xieli Pharmaceutical4.5.1 Sichuan Xieli Pharmaceutical Corporation Information4.5.2 Sichuan Xieli Pharmaceutical Description, Business Overview4.5.3 Sichuan Xieli Pharmaceutical Hesperidin Products Offered4.5.4 Sichuan Xieli Pharmaceutical Hesperidin Sales, Revenue and Gross Margin (2015-2020)4.5.5 Sichuan Xieli Pharmaceutical Hesperidin Revenue by Product4.5.6 Sichuan Xieli Pharmaceutical Hesperidin Revenue by Application4.5.7 Sichuan Xieli Pharmaceutical Hesperidin Revenue by Geographic Area4.5.8 Sichuan Xieli Pharmaceutical Hesperidin Revenue by Sales Channel4.5.9 Sichuan Xieli Pharmaceutical Recent Development4.6 Shaanxi Huifeng Pharmaceutical4.6.1 Shaanxi Huifeng Pharmaceutical Corporation Information4.6.2 Shaanxi Huifeng Pharmaceutical Description, Business Overview4.6.3 Shaanxi Huifeng Pharmaceutical Hesperidin Products Offered4.6.4 Shaanxi Huifeng Pharmaceutical Hesperidin Sales, Revenue and Gross Margin (2015-2020)4.6.5 Shaanxi Huifeng Pharmaceutical Hesperidin Revenue by Product4.6.6 Shaanxi Huifeng Pharmaceutical Hesperidin Revenue by Application4.6.7 Shaanxi Huifeng Pharmaceutical Hesperidin Revenue by Geographic Area4.6.8 Shaanxi Huifeng Pharmaceutical Recent Development4.7 SANREN Bio-Technology4.7.1 SANREN Bio-Technology Corporation Information4.7.2 SANREN Bio-Technology Description, Business Overview4.7.3 SANREN Bio-Technology Hesperidin Products Offered4.7.4 SANREN Bio-Technology Hesperidin Sales, Revenue and Gross Margin (2015-2020)4.7.5 SANREN Bio-Technology Hesperidin Revenue by Product4.7.6 SANREN Bio-Technology Hesperidin Revenue by Application4.7.7 SANREN Bio-Technology Hesperidin Revenue by Geographic Area4.7.8 SANREN Bio-Technology Recent Development4.8 Chengdu Shuxi Pharmaceutical4.8.1 Chengdu Shuxi Pharmaceutical Corporation Information4.8.2 Chengdu Shuxi Pharmaceutical Description, Business Overview4.8.3 Chengdu Shuxi Pharmaceutical Hesperidin Products Offered4.8.4 Chengdu Shuxi Pharmaceutical Hesperidin Sales, Revenue and Gross Margin (2015-2020)4.8.5 Chengdu Shuxi Pharmaceutical Hesperidin Revenue by Product4.8.6 Chengdu Shuxi Pharmaceutical Hesperidin Revenue by Application4.8.7 Chengdu Shuxi Pharmaceutical Hesperidin Revenue by Geographic Area4.8.8 Chengdu Shuxi Pharmaceutical Recent Development4.9 Hunan Yuantong Pharmaceutical4.9.1 Hunan Yuantong Pharmaceutical Corporation Information4.9.2 Hunan Yuantong Pharmaceutical Description, Business Overview4.9.3 Hunan Yuantong Pharmaceutical Hesperidin Products Offered4.9.4 Hunan Yuantong Pharmaceutical Hesperidin Sales, Revenue and Gross Margin (2015-2020)4.9.5 Hunan Yuantong Pharmaceutical Hesperidin Revenue by Product4.9.6 Hunan Yuantong Pharmaceutical Hesperidin Revenue by Application4.9.7 Hunan Yuantong Pharmaceutical Hesperidin Revenue by Geographic Area4.9.8 Hunan Yuantong Pharmaceutical Recent Development4.10 Chengdu Yazhong Bio-pharmaceutical4.10.1 Chengdu Yazhong Bio-pharmaceutical Corporation Information4.10.2 Chengdu Yazhong Bio-pharmaceutical Description, Business Overview4.10.3 Chengdu Yazhong Bio-pharmaceutical Hesperidin Products Offered4.10.4 Chengdu Yazhong Bio-pharmaceutical Hesperidin Sales, Revenue and Gross Margin (2015-2020)4.10.5 Chengdu Yazhong Bio-pharmaceutical Hesperidin Revenue by Product4.10.6 Chengdu Yazhong Bio-pharmaceutical Hesperidin Revenue by Application4.10.7 Chengdu Yazhong Bio-pharmaceutical Hesperidin Revenue by Geographic Area4.10.8 Chengdu Yazhong Bio-pharmaceutical Recent Development4.11 Chengdu Runde Pharmaceutical4.11.1 Chengdu Runde Pharmaceutical Corporation Information4.11.2 Chengdu Runde Pharmaceutical Description, Business Overview4.11.3 Chengdu Runde Pharmaceutical Hesperidin Products Offered4.11.4 Chengdu Runde Pharmaceutical Hesperidin Sales, Revenue and Gross Margin (2015-2020)4.11.5 Chengdu Runde Pharmaceutical Hesperidin Revenue by Product4.11.6 Chengdu Runde Pharmaceutical Hesperidin Revenue by Application4.11.7 Chengdu Runde Pharmaceutical Hesperidin Revenue by Geographic Area4.11.8 Chengdu Runde Pharmaceutical Recent Development4.12 Quzhou Tiansheng Plant Extract4.12.1 Quzhou Tiansheng Plant Extract Corporation Information4.12.2 Quzhou Tiansheng Plant Extract Description, Business Overview4.12.3 Quzhou Tiansheng Plant Extract Hesperidin Products Offered4.12.4 Quzhou Tiansheng Plant Extract Hesperidin Sales, Revenue and Gross Margin (2015-2020)4.12.5 Quzhou Tiansheng Plant Extract Hesperidin Revenue by Product4.12.6 Quzhou Tiansheng Plant Extract Hesperidin Revenue by Application4.12.7 Quzhou Tiansheng Plant Extract Hesperidin Revenue by Geographic Area4.12.8 Quzhou Tiansheng Plant Extract Recent Development4.13 Chengdu Hawk Bio-Engineering4.13.1 Chengdu Hawk Bio-Engineering Corporation Information4.13.2 Chengdu Hawk Bio-Engineering Description, Business Overview4.13.3 Chengdu Hawk Bio-Engineering Hesperidin Products Offered4.13.4 Chengdu Hawk Bio-Engineering Hesperidin Sales, Revenue and Gross Margin (2015-2020)4.13.5 Chengdu Hawk Bio-Engineering Hesperidin Revenue by Product4.13.6 Chengdu Hawk Bio-Engineering Hesperidin Revenue by Application4.13.7 Chengdu Hawk Bio-Engineering Hesperidin Revenue by Geographic Area4.13.8 Chengdu Hawk Bio-Engineering Recent Development4.14 Chongqing Zhuliu Bioengineering4.14.1 Chongqing Zhuliu Bioengineering Corporation Information4.14.2 Chongqing Zhuliu Bioengineering Description, Business Overview4.14.3 Chongqing Zhuliu Bioengineering Hesperidin Products Offered4.14.4 Chongqing Zhuliu Bioengineering Hesperidin Sales, Revenue and Gross Margin (2015-2020)4.14.5 Chongqing Zhuliu Bioengineering Hesperidin Revenue by Product4.14.6 Chongqing Zhuliu Bioengineering Hesperidin Revenue by Application4.14.7 Chongqing Zhuliu Bioengineering Hesperidin Revenue by Geographic Area4.14.8 Chongqing Zhuliu Bioengineering Recent Development4.15 Hunan Kingti Bio-Tech4.15.1 Hunan Kingti Bio-Tech Corporation Information4.15.2 Hunan Kingti Bio-Tech Description, Business Overview4.15.3 Hunan Kingti Bio-Tech Hesperidin Products Offered4.15.4 Hunan Kingti Bio-Tech Hesperidin Sales, Revenue and Gross Margin (2015-2020)4.15.5 Hunan Kingti Bio-Tech Hesperidin Revenue by Product4.15.6 Hunan Kingti Bio-Tech Hesperidin Revenue by Application4.15.7 Hunan Kingti Bio-Tech Hesperidin Revenue by Geographic Area4.15.8 Hunan Kingti Bio-Tech Recent Development 5 Breakdown Data by Type5.1 Global Hesperidin Sales by Type (2015-2026)5.1.1 Global Hesperidin Sales by Type (2015-2020)5.1.2 Global Hesperidin Sales Forecast by Type (2021-2026)5.1.3 Global Hesperidin Sales Market Share by Type (2015-2026)5.2 Global Hesperidin Revenue Forecast by Type (2015-2026)5.2.1 Global Hesperidin Revenue by Type (2015-2020)5.2.2 Global Hesperidin Revenue Forecast by Type (2021-2026)5.2.3 Global Hesperidin Revenue Market Share by Type (2015-2026)5.3 Hesperidin Average Selling Price (ASP) by Type (2015-2026) 6 Breakdown Data by Application6.1 Global Hesperidin Sales by Application (2015-2026)6.1.1 Global Hesperidin Sales by Application (2015-2020)6.1.2 Global Hesperidin Sales Forecast by Application (2021-2026)6.1.3 Global Hesperidin Sales Market Share by Application (2015-2026)6.2 Global Hesperidin Revenue Forecast by Application (2015-2026)6.2.1 Global Hesperidin Revenue by Application (2015-2020)6.2.2 Global Hesperidin Revenue Forecast by Application (2021-2026)6.2.3 Global Hesperidin Revenue Market Share by Application (2015-2026)6.3 Hesperidin Average Selling Price (ASP) by Application (2015-2026) 7 North America7.1 North America Hesperidin Market Size YoY Growth 2015-20267.2 North America Hesperidin Market Facts & Figures by Country7.2.1 North America Hesperidin Sales by Country (2015-2026)7.2.2 North America Hesperidin Revenue by Country (2015-2026)7.3 North America Hesperidin Sales by Type7.4 North America Hesperidin Sales by Application 8 Asia-Pacific8.1 Asia-Pacific Hesperidin Market Size YoY Growth 2015-20268.2 Asia-Pacific Hesperidin Market Facts & Figures by Region8.2.1 Asia-Pacific Hesperidin Sales by Region (2015-2026)8.2.2 Asia-Pacific Hesperidin Revenue by Region (2015-2026)8.3 Asia-Pacific Hesperidin Sales by Type8.4 Asia-Pacific Hesperidin Sales by Application 9 Europe9.1 Europe Hesperidin Market Size YoY Growth 2015-20269.2 Europe Hesperidin Market Facts & Figures by Country9.2.1 Europe Hesperidin Sales by Country (2015-2026)9.2.2 Europe Hesperidin Revenue by Country (2015-2026)9.3 Europe Hesperidin Sales by Type9.4 Europe Hesperidin Sales by Application 10 Latin America10.1 Latin America Hesperidin Market Size YoY Growth 2015-202610.2 Latin America Hesperidin Market Facts & Figures by Country10.2.1 Latin America Hesperidin Sales by Country (2015-2026)10.2.2 Latin America Hesperidin Revenue by Country (2015-2026)10.3 Latin America Hesperidin Sales by Type10.4 Latin America Hesperidin Sales by Application 11 Middle East and Africa11.1 Middle East and Africa Hesperidin Market Size YoY Growth 2015-202611.2 Middle East and Africa Hesperidin Market Facts & Figures by Country11.2.1 Middle East and Africa Hesperidin Sales by Country (2015-2026)11.2.2 Middle East and Africa Hesperidin Revenue by Country (2015-2026)11.3 Middle East and Africa Hesperidin Sales by Type11.4 Middle East and Africa Hesperidin Sales by Application 12 Supply Chain and Sales Channel Analysis12.1 Hesperidin Supply Chain Analysis12.2 Hesperidin Key Raw Materials and Upstream Suppliers12.3 Hesperidin Clients Analysis12.4 Hesperidin Sales Channel and Sales Model Analysis12.4.1 Hesperidin Distribution Channel Analysis: Indirect Sales VS Direct Sales12.4.2 Hesperidin Distribution Channel Analysis: Online Sales VS Offline Sales12.4.3 Hesperidin Distributors 13 Market Dynamics13.1 Hesperidin Market Drivers13.2 Hesperidin Market Opportunities13.3 Hesperidin Market Challenges13.4 Hesperidin Market Restraints13.5 Porters Five Forces Analysis 14 Research Findings and Conclusion 15 Appendix15.1 Research Methodology15.1.1 Methodology/Research Approach15.1.2 Data Source15.2 Author Details15.3 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Go here to read the rest:
Hesperidin Market size was US$ 81 million and it is expected to reach US$ 125.2 million by the end of 2026, with a CAGR of 6.3% - The Daily Chronicle